A randomised comparison of paclitaxel (T) and carboplatin (J) versus a control arm of single agent carboplatin (J) or cyclophosphamide, doxorubicin and cisplatin (CAP): 2074 patients randomised into the 3rd International Collaborative Ovarian Neoplasm Study (ICON3).

被引：0
|
作者：
Poole, CJ [1 ]
机构：
[1] MRC, Clin Trial Unit, Canc Div, Cambridge, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
211
引用
收藏
页码：14 / 14
页数：1
相关论文
共 2 条
  • [1] Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial
    Parmar, MKB
    Adams, M
    Balestrino, M
    Bertelsen, K
    Bonazzi, C
    Calvert, H
    Colombo, N
    Delaloye, JF
    Durando, A
    Guthrie, D
    Hagen, B
    Harper, P
    Mangioni, C
    Perren, T
    Poole, C
    Qian, W
    Rustin, G
    Sandercock, J
    Tumolo, S
    Torri, V
    Vecchione, F
    LANCET, 2002, 360 (9332): : 505 - 515
  • [2] ICON2:: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer
    Parmar, MKB
    Torri, V
    Bonaventura, A
    Bonazzi, C
    Colombo, N
    Delaloye, JF
    Marsoni, S
    Mangioni, C
    Sandercock, J
    Sessa, C
    Williams, C
    Tinazzi, A
    Flann, M
    Geiser, K
    Scorpiglione, N
    Stewart, JF
    Chaves, J
    Palmeiro, E
    Curtain, A
    McCormack, T
    Gennatas, C
    Marras, F
    Oppo, TG
    Balestrino, M
    Malzoni, C
    Malzoni, M
    Belli, M
    Geminiani, ML
    Crestani, G
    Monaco, A
    Vavala, V
    Piatto, E
    Barattini, G
    Fornara, PG
    Chetri, MC
    Santeufemia, G
    Artioli, F
    Carone, D
    Fanizza, G
    Trentadue, R
    Priolo, D
    Scollo, P
    Nigro, SC
    Petrina, M
    Mastrantonio, P
    Spanna, GD
    Zagni, R
    Belloni, C
    Colleoni, R
    Redaelli, L
    LANCET, 1998, 352 (9140): : 1571 - 1576
1